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Introduction
Telomeres, which are composed of tandem repeats of the 
TTAGGG sequence and associated proteins, are nucleoprotein 
structures that cap the ends of chromosomes (for reviews see 
Blackburn, 2001; Chan and Blackburn, 2002; de Lange, 2005). 
Telomere length is maintained by telomerase, a reverse tran-
scriptase that counteracts telomere shortening associated with 
cell division by de novo addition of telomere repeats onto chro-
mosome ends (for review see Chan and Blackburn, 2002). 
Telomerase is expressed in the stem cell compartment of several 
adult tissues, where it is thought to compensate for telomere 
shortening associated with cell proliferation and tissue regenera-
tion (for reviews see Collins and Mitchell, 2002; Harrington, 
2004; Flores et al., 2005, 2006; Sarin et al., 2005). Interestingly, 
telomerase activity levels are not suffi  cient to maintain telomere 
length during human aging, and telomeres progressively shorten 
with increasing age in the context of the organism (Harley et al., 
1990; Canela et al., 2007; for review see Blasco, 2005) and are 
also associated with different disease states (Samani et al., 2001; 
Wiemann et al., 2002; Cawthon et al., 2003; Epel et al., 2004; 
Valdes et al., 2005). Indeed, telomerase levels in humans and 
mice are thought to be rate limiting for organismal life span. 
In particular, reduced telomerase activity caused by mutations in 
telomerase components in the human diseases dyskeratosis con-
genita (Mitchell et al., 1999; Vulliamy et al., 2001, 2004; Mason 
et al., 2005), aplastic anemia (Marrone et al., 2004; Yamaguchi 
et al., 2005), and idiopathic pulmonary fi  brosis (Armanios et al., 
2007; Tsakiri et al., 2007) leads to accelerated telomere shortening, 
premature loss of tissue regeneration, and premature death. Some 
of these phenotypes are shared by telomerase-defi  cient mice 
(Terc
−/− mice; Blasco et al., 1997), which show a reduction in 
both the median and the maximum life span already within the 
fi  rst mouse generation (García-Cao et al., 2006). Furthermore, 
these defects are anticipated with subsequent Terc
−/− mouse gener-
ations with progressively shorter telomeres concomitant with pre-
mature loss of tissue regeneration and organismal survival (Lee 
et al., 1998; Herrera et al., 1999; Leri et al., 2003; Flores et al., 
2005; García-Cao et al., 2006). Similarly, disease anticipation has 
also been reported with increasing generations of human dyskera-
tosis congenita patients (Vulliamy et al., 2004).
The telomerase-defi  cient mouse model has been instru-
mental in understanding the effects of telomere shortening on 
stem cell biology (for review see Blasco, 2005). In particular, 
we recently showed that telomere shortening results in an im-
paired capacity of hair follicle (HF) stem cells to regenerate the 
hair and the skin because of a defective mobilization of the HF 
stem cells out of their niche (Flores et al., 2005). This defective 
stem cell behavior anticipates the fact that telomerase-defi  cient 
mice show premature skin-aging phenotypes such as decreased 
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rgan homeostasis and organismal survival are 
related to the ability of stem cells to sustain tissue 
regeneration. As a consequence of accelerated 
telomerase shortening, telomerase-deﬁ  cient mice show de-
fective tissue regeneration and premature death. This suggests 
a direct impact of telomere length and telomerase activity 
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meres impair the ability of epidermal stem cells to mobilize 
out of the hair follicle (HF) niche, resulting in impaired 
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that telomerase reintroduction in mice with critically short 
telomeres is sufﬁ  cient to correct epidermal HF stem cell 
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mice results in a normal life span by preventing degenerative 
pathologies in the absence of increased tumorigenesis.
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wound healing, hair loss, and hair graying (Lee et al., 1998; 
Herrera et al., 1999; Rudolph et al., 1999), as well as decreased 
skin cancer, as indicated by the fact that they are resistant to 
skin carcinogenesis protocols (Gonzalez-Suarez et al., 2000). 
These fi  ndings suggested that the progressive telomere shorten-
ing that occurs in human tissues with increasing age might di-
rectly impact the ability of different adult stem cell populations 
to maintain tissue homeostasis. Furthermore, these results opened 
the possibility that restoration of telomerase activity may be 
suffi  cient to correct stem cell defects associated with short telo-
meres and to extend the organismal life span.
Here, we demonstrate that restoration of a copy of the 
Terc gene into late generation G3/G4 telomerase-defi  cient mice 
is suffi  cient to elongate critically short telomeres in skin kerati-
nocytes from these mice, prevent end-to-end chromosome fu-
sions, and rescue both HF stem cell defects in vivo and the 
impaired proliferative capacity of epidermal stem cells ex vivo. 
Finally, telomerase reintroduction was able to extend the nor-
mal life span of G4 telomerase-defi  cient mice by preventing de-
generative pathologies in the absence of increased cancer. These 
fi  ndings support the notion that telomerase activators would be 
suffi  cient to correct stem cell defects in tissues with critically 
short telomeres in the absence of undesired effects.
Results
Reintroduction of the telomerase Terc gene 
in late generation Terc-deﬁ  cient mice is 
sufﬁ  cient to elongate critically short 
telomeres and prevent chromosomal 
instability in skin keratinocytes
To test whether telomerase reintroduction was able to elongate 
short telomeres in skin keratinocytes from late generation G3/G4 
Terc-defi  cient mice, we fi  rst generated large colonies of litter-
mate mice from Terc
+/− × G2/G3 Terc
−/− intercrosses (Materials 
and methods). The progeny of these crosses was divided into 
two mouse cohorts according to their telomerase status: G3/G4 
Terc
−/− telomerase-defi  cient mice and G3/G4 Terc
+/− telomerase-
reconstituted mice (referred to here as G3/G4 Terc
+/−* mice). 
Importantly, both mouse cohorts inherited the same telomere 
length from the parents; however, G3/G4 Terc
−/− mice lack 
telomerase activity and G3/G4 Terc
+/−* mice are telomerase 
profi  cient (Fig. 1). To address whether telomerase activity in 
G3 Terc
+/−* mice was able to rescue short telomeres compared 
with G3 Terc
−/− cohorts, we measured telomere length using 
quantitative FISH (Q-FISH) on primary keratinocytes obtained 
from newborn mice (Gonzalez-Suarez et al., 2000; Muñoz et al., 
2005; Materials and methods). G3 Terc
+/−* skin keratinocytes 
showed, on average, longer telomeres than those from the corre-
sponding G3 Terc
−/− littermates (P < 0.001; Fig. 2, A and B). 
Furthermore, this telomere elongation coincided with a signifi  -
cant reduction of the percentage of short telomeres (<100 arbi-
trary units of fl  uorescence [a.u.f.]) in G3 Terc
+/−* mice compared 
with the corresponding G3 Terc
−/− littermates (P < 0.001; Fig. 2, 
A and B), which is in agreement with previous fi  ndings showing 
that telomerase preferentially elongates short telomeres both in 
yeast and mammals (Hemann et al., 2001; Samper et al., 2001; 
Teixeira et al., 2004). The percentage of longest telomeres 
(>1,000 a.u.f.) was also signifi  cantly increased in telomerase-
reconstituted G3 Terc
+/−* mice compared with the corresponding 
G3 Terc
−/− littermates (P = 0.015; Fig. 2, A and B), in agreement 
with the increase in mean telomere length.
Finally, we determined whether the elongated telomeres 
in G3 Terc
+/−* keratinocytes correlated with a signifi  cant rescue 
of chromosomal aberrations associated with critically short 
telomeres. For this, we performed a full karyotypic analysis 
Figure 1.  Reconstitution of telomerase activity 
in G3 Terc
+/−* mice compared with their G3 
Terc
−/− siblings. Telomerase is successfully re-
constituted in two independent MEF cultures 
from G3 Terc
+/−* mice compared with their tel-
omerase-deﬁ  cient  G3  Terc
−/− littermates. Two 
wild-type MEFs are also included as a positive 
control for telomerase activity. The protein con-
centration used is indicated on top of each lane. 
Extracts were treated (+) or not treated (−) with 
RNase as a negative control. An internal control 
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using telomere Q-FISH on metaphases (Materials and methods). 
As shown in Fig. 3 (A and B), telomerase-reconstituted G3 
Terc
+/−* keratinocytes showed a signifi  cant rescue of chromo-
somal abnormalities associated with critically short telomeres, 
such as signal-free ends and end-to-end fusions, compared with 
the corresponding G3 Terc
−/− controls (P < 0.001 for all com-
parisons), suggesting that these types of aberrations are the di-
rect consequence of critical telomere shortening and that when 
short telomeres are reelongated by telomerase they are com-
pletely prevented. In contrast, breaks and fragments are not res-
cued by telomerase reintroduction, indicating that they are not 
the direct consequence of critical telomere shortening.
Reintroduction of the telomerase Terc gene 
into G3/G4 Terc-deﬁ  cient mice is sufﬁ  cient 
to rescue mobilization defects of epidermal 
HF stem cells
To investigate whether elongation of short telomeres by telomer-
ase in skin keratinocytes was suffi  cient to rescue epidermal stem 
cell defects in late generation telomerase-defi  cient mice (Flores 
et al., 2005), we compared the number and mobilization ability 
of epidermal stem cells in the HF stem cell niche before and after 
mitogenic activation in G3 Terc
+/−* mice with that of the corre-
sponding G3 Terc
−/− littermates (Fig. 4, A–C). To visualize HF 
stem cells, we used a labeling technique previously shown to 
mark self-renewing and multipotent epidermal cells, the so-called 
label retaining cells (LRCs; for review see Fuchs et al., 2004; 
Flores et al., 2005; Moore and Lemischka, 2006). Of notice, these 
experiments were performed in young mice (0–2 mo old) from 
both genotypes before any skin phenotypes associated with short 
telomeres were detectable. Confocal microscopy revealed that 
LRCs are enriched at the bulge area of the HF in the two geno-
types, which is in agreement with the known location of the 
HF stem cell niche (Fig. 4 C; Cotsarelis et al., 1990; Oshima 
et al., 2001; Morris et al., 2004; Tumbar et al., 2004).
In control resting skin conditions, we did not detect sig-
nifi  cant differences in the numbers of LRCs at the hair bulge of 
G3 Terc
+/−* mice compared with the corresponding G3 Terc
−/− 
littermates (P = 0.090; Fig. 4, A and C). To test whether the hair 
bulge stem cells were able to mobilize (exit their quiescence 
state and migrate) out of the niche, we studied the response of 
G3 Terc
−/− and G3 Terc
+/−* LRCs to 12-O-tetradecanoylphorbol-
13-acetate (TPA) treatment, a potent tumor promoter that ac-
tivates LRCs to give numerous progeny (Flores et al., 2005). 
Figure 2.  Rescue of mean telomere length and percentage of short telomeres in late generation telomerase-reconstituted G3 Terc
+/−* keratinocytes. 
(A) Telomere length histogram obtained by Q-FISH in primary murine skin keratinocytes. The histogram shown is representative of three independent pairs of 
G3 Terc
−/− and G3 Terc
+/−* littermates (see B). Note a greater abundance of short telomeres in the G3 Terc
−/− mouse compared with the G3 Terc
+/−* littermate. 
Red lines facilitate visualization of short (<100 a.u.f.) and long (>1,000 a.u.f.) telomeres. The total number of telomere dots used for the quantiﬁ  cation and 
the percentage of short and long telomeres are indicated. (B) Mean telomere length is signiﬁ  cantly increased (P < 0.001) in G3 Terc
+/−* compared with 
G3 Terc
−/− mice. Concomitantly, these mice show a signiﬁ  cant (P < 0.001) decrease in the percentage of short telomeres and a signiﬁ  cant (P = 0.015) 
increase in the percentage of long telomeres. Data are mean values ± SEM for three independent pairs of G3 Terc
−/− and G3 Terc
+/−* littermates.JCB • VOLUME 179 • NUMBER 2 • 2007  280
TPA treatment results in rapid disappearance of LRCs (Braun 
et al., 2003), skin hyperplasia (Gonzalez-Suarez et al., 2000), 
and entry of HFs into their anagen (growing) phase (Wilson et al., 
1994). After TPA treatment, only 34% of the LRCs mobilized 
out of the HF niche in G3 Terc
−/− mice (Fig. 4, B and C) com-
pared with the previously reported 70% mobilization in wild-
type mice of different genetic backgrounds (Flores et al., 2005), 
thus confi  rming the defective stem cell mobilization associated 
with short telomeres. In contrast, 65% of LRCs mobilized in 
TPA-treated G3 Terc
+/−* mice (P = 0.006; Fig. 4 B). A similar 
rescue in HF stem cell mobilization defects was obtained when 
comparing G4 Terc
+/−* mice to the corresponding G4 Terc
−/− 
littermates (Fig. S1, A–C, available at http://www.jcb.org/cgi/
content/full/jcb.200704141/DC1). Collectively, these results 
demonstrate that telomerase reintroduction in late generation 
G3 and G4 Terc
+/−* mice signifi  cantly rescues epidermal HF 
Figure 3.  Signiﬁ  cant rescue of signal-free ends and end-to-end chromosomal fusions in G3 Terc
+/−* keratinocytes. (A) Quantiﬁ  cation of the frequency of the 
indicated chromosomal aberrations in primary keratinocytes from G3 Terc
−/− and G3 Terc
+/−* mice. The total number of chromosomes scored for the analysis 
is indicated on top of each bar. Statistical comparisons using the χ
2 test are shown. (B) Representative examples of the indicated chromosomal aberrations 
are shown below the graph. Note that signal-free ends and end-to-end fusions are signiﬁ  cantly rescued in Terc-reconstituted G3 mice compared with the 
G3 Terc-deﬁ  cient littermates, which is in agreement with the fact that telomerase elongates short telomeres, thus preventing telomere dysfunction. Bar, 0.4 m.
Figure 4.  Rescue of HF stem cell mobilization defects, as well as of skin and hair growth defects in late generation telomerase-reconstituted G3 Terc
+/−* 
mice upon TPA treatment. (A and B) To assay mobilization of LRCs, mice of the indicated genotype were injected with BrdU and after 69 d, whole mounts 
of tail epidermis were collected from untreated and TPA-treated mice and stained with a BrdU antibody. The number of LRCs at the hair bulge in resting con-
ditions or after stimulation with TPA in littermate G3 Terc
+/−* and G3 Terc
−/− mice are indicated (A). LRC numbers were calculated in at least ﬁ  ve mice of 
each genotype (n), quantifying at least 197 follicles in the control group and at least 190 follicles in the TPA-treated group (A). Note a higher percentage 
of mobilization of LRCs in TPA-treated G3 Terc
+/−* mice compared with G3 Terc
−/− mice (B). (C) Representative confocal micrographs of tail follicles from 
G3 Terc
−/− and G3 Terc
+/−* mice were stained for BrdU (green) before (controls) and after (+TPA) TPA treatment. LRCs of all genotypes accumulate in the 
bulge (Bu) region of the HF. Bar, 80 μm. Note a greater disappearance of LRCs in Terc
+/−* TPA-treated HFs compared with the G3 Terc
−/− littermates. 
The different compartments (infundibulum, hair bulge, and hair bulb) of the HF are indicated. (D–G) Quantiﬁ  cation of HF length from sebaceous glands 
(SG) to dermal papilla (DP; D and E) and of IFE thickness (F and G) in tail skin from mice of the indicated genotype. Histomorphometry was performed in 
ﬁ  ve mice of each genotype (n), quantifying at least 69 follicles in the control group and at least 76 follicles in the TPA-treated group. Note the increased 
HF length and IFE thickness in TPA-treated G3 Terc
+/−* mice compared with G3 Terc
−/− littermates (P < 0.05 for both; E and G). (H) Representative tail 
skin sections from mice of the indicated genotypes before (control) and after (+TPA) TPA treatment. Bracketed continuous black lines mark IFE. Black dashed 
double-pointed arrows mark HF length from sebaceous glands to dermal papilla. Bar, 150 m. Error bars in A, B, and D–G represent SEM.TELOMERASE RESCUES STEM CELL DEFECTS • SIEGL-CACHEDENIER ET AL. 281JCB • VOLUME 179 • NUMBER 2 • 2007  282
stem cell mobilization defects compared with the G3 and G4 
Terc
−/− littermates.
In agreement with the defects in HF stem cell mobilization 
associated with short telomeres, HF length was not signifi  cantly 
increased in G3 Terc
−/− mice after TPA treatment (P = 0.80; 
Fig. 4, D, E, and H), refl  ecting a defective HF anagen response in 
these mice after TPA treatment (Flores et al., 2005). Again, telom-
erase reintroduction rescued this defect in G3 Terc
+/−* littermates, 
where HF length was signifi  cantly increased in response to TPA 
treatment compared with resting nontreated skin (P < 0.001; Fig. 4, 
D, E, and H), suggesting that telomerase is suffi  cient to restitute 
skin homeostasis in these mice. Similar results were obtained for 
increased interfollicular epidermis (IFE) thickness in response to 
TPA treatment. Again, telomerase reintroduction in G3 Terc
+/−* 
littermates resulted in increased IFE hyperplasia compared 
with littermate G3 Terc
−/− mice in response to TPA treatment 
(P < 0.05; Fig. 4, F–H). To study whether the increased IFE hyper-
plasia in G3 Terc
+/−* mice compared with the G3 Terc
−/− controls 
was associated with signifi  cant differences in cell proliferation or 
apoptosis, we performed immunohistochemistry of skin sections 
with antibodies against Ki67 and caspase 3 to detect prolifera-
ting and apoptotic cells, respectively (Materials and methods). 
As shown in Fig. S2 (avail  able at http://www.jcb.org/cgi/content/
full/jcb.200704141/DC1), we did not detect considerable differ-
ences in the percentage of Ki67-positive cells between G3 Terc
+/−* 
and G3 Terc
−/− either in resting skin conditions or upon TPA treat-
ment. Similarly, we were unable to detect caspase 3–positive cells 
in the skin of G3 Terc
+/−* and G3 Terc
−/− mice, suggesting that 
apoptosis is not a major cellular response to critically short telo-
meres in the skin (Fig. S3). Finally, we studied whether there were 
differences in skin differentiation markers between G3 Terc
+/−* 
and G3 Terc
−/− mice by performing immunohistochemistry with 
antibodies against K14 and p63, two skin basal-layer markers 
whose expression is normally reduced at the suprabasal skin lay-
ers (Materials and methods). We could not detect signifi  cant dif-
ferences in the percentage of cells or in the number of keratinocyte 
layers positive for these markers (Figs. S4 and S5).
Next, we used hair-plucking experiments as an indepen-
dent way to induce entry of HFs into their anagen phase (Flores 
et al., 2005; Materials and methods). In control resting skin 
conditions, we did not detect differences in back skin HF length 
and dermis thickness between G3 Terc
−/− and G3 Terc
+/−* 
littermates (P = 0.71 and P = 0.49, respectively; Fig. 5, A, C, 
and E). Upon hair plucking, however, G3 Terc
+/−* mice showed 
a signifi  cantly increased back skin HF length and dermis thick-
ness compared with the corresponding G3 Terc
−/− littermates 
(P = 0.04 and P = 0.09, respectively; Fig. 5, A–E), again 
demonstrating that telomerase reintroduction in mice with short 
telomeres is able to improve the ability of epidermal HF stem 
cells to mobilize and regenerate the hair and skin.
Rescue of proliferative potential of 
epidermal stem cells ex vivo in late 
generation telomerase-reconstituted 
G3 Terc
+/−* mice
It has been previously described that the epidermal stem cell de-
fects observed in late generation telomerase-defi  cient mice are cell 
autonomous, as indicated by a defective clonogenic potential of 
these cells ex vivo (Flores et al., 2006). Individual colonies in clono-
genic assays have been proposed to derive from single stem cells 
(Barrandon and Green, 1987; Materials and methods). Here, we 
performed clonogenic assays to compare the proliferation potential 
of telomerase-defi  cient G3 Terc
−/− and telomerase-reconstituted 
G3 Terc
+/−* epidermal stem cells (Materials and methods). 
In agreement with the in vivo results shown in Fig. 4, primary 
keratinocytes from newborn G3 Terc
−/− mice formed fewer and 
smaller colonies than those from wild-type controls (P < 0.001; 
Fig. 6, A and B), refl  ecting the previously described defective 
capacity of late generation Terc-null epidermal stem cells to pro-
liferate ex vivo (Flores et al., 2005). Interestingly, the defective 
clonogenic potential of these cells was signifi  cantly corrected in 
telomerase-reconstituted G3 Terc
+/−* keratinocytes compared 
with the corresponding G3 Terc
−/− controls (P = 0.006; Fig. 6, 
A and B), demonstrating that telomerase reintroduction amelio-
rates the ex vivo proliferative capacity of epidermal stem cells 
from late generation telomerase-defi  cient mice.
Reintroduction of the telomerase Terc gene 
in G3 Terc-deﬁ  cient mice is sufﬁ  cient to 
rescue their small body-size phenotype
We have previously described that late generation telomerase-
defi  cient mice show a small body-size phenotype at the time of 
birth, which is associated with shorter telomeres in these mice as 
well as with a decreased clonogenic potential of epidermal stem 
cells in vitro (Flores et al., 2005). These observations opened the 
intriguing possibility that body size and stem cell proliferative 
potential may be mechanistically related. Here, we fi  rst con-
fi  rmed that newborn G3 Terc
−/− mice showed a signifi  cantly 
lower body weight at the time of birth compared with the wild-
type controls (P < 0.001; Fig. 6, C and D, left), which again was 
concomitant with a lower clonogenic potential of keratinocytes 
derived from G3 Terc
−/− mice compared with the wild types 
(Fig. 6, A and B). Interestingly, the small body-size phenotype 
of newborn G3 Terc
−/− mice was signifi   cantly corrected by 
telomerase reintroduction into G3 Terc
+/−* newborns, parallel-
ing the rescue of stem cell phenotypes in these mice (Figs. 4–6). 
This signifi  cant rescue of the small body-size phenotype observed 
in newborns was maintained when comparing age-matched adult 
(2 mo old) G3 Terc
+/−* mice to the corresponding G3 Terc
−/− 
littermates (P < 0.001; Fig. 6, C and D, right). These results 
support that the small body size of telomerase-defi  cient mice 
may be linked to decreased stem cell functionality.
Reintroduction of the telomerase Terc gene 
in G3 Terc-deﬁ  cient mice is sufﬁ  cient to 
rescue a normal life span in the absence of 
increased cancer
The results presented here for epidermal HF stem cells open the 
possibility that telomerase reintroduction into mice with criti-
cally short telomeres may be suffi  cient to restore stem cell 
functionality in different tissues, thus rescuing life span and 
long-term survival. To address this, we studied the long-term 
survival and maximum life span of both telomerase-reconstituted 
G4 Terc
+/−* and telomerase-defi  cient G4 Terc
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compared with that of control wild-type mice as well as control 
nonreconstituted heterozygous Terc
+/− mice (Fig. 7, A–C). 
First, we confi  rmed a dramatic decrease in the maximum life 
span of G4 Terc
−/− mice compared with wild-type and Terc
+/− 
controls, which went from  130 and 140 wk, respectively, to 
<50 wk in the case of G4 Terc
−/− mice (P < 0.001; Fig. 7 A). 
G4 Terc
−/− mice also showed a signifi  cantly decreased median 
survival compared with the wild-type and Terc
+/− controls 
(P < 0.001; Fig. 7 B). Importantly, telomerase-reconstituted 
G4  Terc
+/−* mice showed a survival curve and a median 
survival that is indistinguishable from that of wild-type and 
Terc
+/− controls (Fig. 7, A and B, NS; P = . 0.56), indicating 
Figure 5.  Rescue of skin and hair growth defects in late gener-
ation telomerase-reconstituted G3 Terc
+/−* mice upon hair pluck-
ing of back skin. (A–D) Quantiﬁ  cation of HF length from IFE to 
dermal papilla (A and B) and of dermis thickness (C and D) in 
back skin from mice of the indicated genotype. Histomorphome-
try was performed in ﬁ  ve mice of each genotype, quantifying at 
least 55 follicles in the control groups and at least 87 follicles in 
the TPA-treated groups. Note the increased HF length and der-
mis thickness in G3 Terc
+/−* mice compared with G3 Terc
−/− lit-
termates after plucking (B and D). Error bars represent SEM. 
(E) Representative back skin sections from mice of the indicated 
genotypes before (control) and after (pluck) plucking. Black double-
pointed arrows mark dermis thickness. Arrowheads mark HF length 
from IFE to dermal papilla. Bar, 480 m.JCB • VOLUME 179 • NUMBER 2 • 2007  284
that telomerase reintroduction into mice with critically short 
telomeres is suffi  cient to restore a normal long- term survival in 
these mice.
Next, we studied whether telomerase-reconstituted G4 
Terc
+/−* mice had a different spectrum of cancer and aging 
pathologies compared with control wild-type and Terc
+/− 
Figure 6.  Rescue of proliferative potential of epidermal stem cells 
ex vivo and of small body-size phenotype in late generation telomerase-
reconstituted G3 Terc
+/−* mice. (A) Representative images of number 
and size of macroscopic colonies obtained from isolated keratino-
cytes of the indicated genotypes. Note more abundant and larger 
colonies in G3 Terc
+/−* mice compared with G3 Terc
−/− littermates. 
(B) Quantiﬁ  cation of size and number of macroscopic colonies obtained 
from isolated keratinocytes of the indicated genotype puriﬁ  ed from 
2-d-old mice and cultured for 10 d on J2-3T3 mitomycin C–treated 
feeder ﬁ  broblasts. (C) Representative images of newborn (left) and 
2-mo-old (right) mice of the indicated genotype. Note a small body 
size in G3 Terc
−/− mice compared with wild-type controls and that this 
small body-size phenotype is largely rescued in telomerase-reconstituted 
G3 Terc
+/−* mice. (D) Quantiﬁ  cation of body weight in newborn (left) 
and 2-mo-old (right) mice of the indicated genotypes. Note signiﬁ  cantly 
reduced body size in newborn G3 Terc
−/− mice compared with both 
wild-type controls and telomerase-reconstituted G3 Terc
+/−* mice 
(P < 0.001 for both) and the signiﬁ  cantly reduced body size in adult 
G3 Terc
−/− mice compared with telomerase-reconstituted G3 Terc
+/−* 
mice (P < 0.001). Error bars in B and D represent SEM.TELOMERASE RESCUES STEM CELL DEFECTS • SIEGL-CACHEDENIER ET AL. 285
heterozygous mice. Telomerase-defi  cient G3 and G4 Terc
−/− mice 
have a dramatic reduction in the incidence of malignant tumors 
compared with wild-type and normal Terc
+/− heterozygous 
mice (Fig. 7 D), which is in agreement with a potent tumor 
suppressor role for short telomeres in the context of telomerase 
defi  ciency (Greenberg et al., 1999; Gonzalez-Suarez et al., 2000; 
Blasco and Hahn, 2003). In contrast, G4 Terc
+/−* mice showed 
a similar or higher incidence of malignant tumors at time of 
Figure 7.  Rescue of organismal life span in late generation 
telomerase-reconstituted G3 Terc
+/−* mice. (A) Kaplan-Meyer 
survival curve of mice of the indicated genotype. n is the 
number of mice of each genotype. Statistical comparisons using 
the log rank test are also shown. Note the signiﬁ  cant rescue 
in survival of telomerase-reconstituted G3 Terc
+/−* mice com-
pared with G3 Terc
−/− mice (P < 0.001). (B) Median survival 
obtained from Kaplan-Meyer plots of mice of the indicated 
genotypes. Statistical comparisons using the log rank test are 
also shown. Note the signiﬁ  cantly reduced median survival of 
G3 Terc
−/− mice compared with the other genotypes (P < 
0.001). (C) Maximal lifespan of mice of the indicated geno-
types. Note the decreased maximal life span of G3 Terc
−/− 
mice and how this is corrected in telomerase-reconstituted G3 
Terc
+/−* mice. (D) Percentage of mice of the indicated genotype 
showing malignant tumors (lymphoma, histiocytic sarcoma, 
or sarcoma/carcinoma) at the time of death. Statistical com-
parisons using the χ
2 test are also shown. Note the decreased 
incidence of malignant tumors in G3 and G4 Terc
−/− mice in 
agreement with a tumor-suppressor role associated with telom-
erase deﬁ  ciency and short telomeres. Telomerase-reconstituted 
G4 Terc
+/−* mice show a similar tumor incidence to that of 
wild-type controls. (E) Percentage of mice of the indicated 
genotype showing degenerative pathologies (atrophies) in 
the indicated tissues at the time of death. Statistical comparisons 
using the χ
2 test are also shown. Note the decreased incidence 
of intestinal atrophies in telomerase-reconstituted G4 Terc
+/−* 
mice compared with G3 and G4 Terc
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death (lymphomas, sarcomas, and carcinomas) compared with that 
of wild-type and Terc
+/− heterozygous controls, respectively 
(Fig. 7 D), suggesting that telomerase reintroduction is suffi  cient 
to sustain normal tumorigenesis in G4 Terc
+/−* mice. Of notice, 
the increased tumorigenesis in G4 Terc
+/−* mice compared 
with nonreconstituted Terc
+/− heterozygous controls (P < 0.001; 
Fig. 7 D)  may be related to the fact that not all chromosomal 
defects associated with short telomeres are rescued by telomerase 
reintroduction (i.e., fragments and breaks; Fig. 3).
Finally, telomerase-reconstituted G4 Terc
+/−* mice also 
showed a signifi  cant rescue of degenerative pathologies com-
pared with G3 and G4 Terc
−/− mice. In particular, atrophies of 
the small intestine appeared in only 6% of G4 Terc
+/−* mice at 
time of death compared with 100% of the G3 and G4 Terc
−/− 
mice (Fig. 7 E). Importantly, degenerative pathologies in G4 
Terc
+/−* mice showed a similar incidence to those of aged-
matched normal Terc
+/− controls with a similar dose of the Terc 
allele, illustrating a complete rescue of degenerative patholo-
gies associated with late generation Terc
−/− mice. Collectively, 
these results suggest that telomerase reconstitution into mice 
with critically short telomeres is suffi  cient to confer a normal 
life span and normal aging in the absence of abnormally in-
creased tumorigenesis.
Finally, in agreement with the similar incidence of de-
generative pathologies and cancer, mean telomere length, as well 
as the percentages of short and long telomeres, was indistin-
guishable between telomerase-reconstituted G3/G4 Terc
+/−* mice 
and the Terc
+/− controls in both age-matched adult skin kerati-
nocytes (10 mo old; Fig. 8, A and B) and primary splenocytes 
(12–24 mo old; Fig. 8, C and D), suggesting that telomerase 
activity with a normal telomere length is able to provide homeo-
stasis during the life span of these mice.
Discussion
The mechanisms by which short telomeres negatively impact 
on organismal aging and life span are still far from being under-
stood. One of the proposed mechanisms, which has gained in-
creasing experimental support, is the progressive loss of stem 
cell functionality associated with critically short telomeres. 
Evidence for this comes from the study of the telomerase-defi  cient 
mouse model, which shows impaired stem cell functionality in 
several tissues including the bone marrow, the brain, and the skin 
(Lee et al., 1998; Samper et al., 2002; Ferron et al., 2004; Flores 
et al., 2005). In particular, we have recently shown that late 
generation telomerase-defi  cient mice show an impaired ability of 
epidermal stem cells to mobilize out of their niches and to regen-
erate the skin and the hair. This defective stem cell behavior 
anticipates the fact that telomerase-defi  cient mice show premature 
aging of the hair and the skin as well as an increased resistance 
to developing skin cancer (Lee et al., 1998; Herrera et al., 1999; 
Rudolph et al., 1999; Gonzalez-Suarez et al., 2000), supporting 
the notion that short telomeres provoke aging by impairing the 
functionality of stem cells.
Here, we provide further support for a stem cell theory of 
telomere-mediated aging by showing that telomerase reintroduc-
tion in late generation telomerase-defi  cient mice is suffi  cient to 
restore a normal behavior of epidermal HF stem cells and a nor-
mal skin functionality in these mice, therefore supporting the 
notion that stem cells are important players in the known role of 
telomeres and telomerase in aging. In this regard, we show that 
epidermal HF stem cell defects of late-generation Terc-defi  cient 
mice are independent of proliferation rates, apoptosis, or ex-
pression of the K14 and p63 differentiation markers in the skin, 
similar to Terc
−/− and Terc
+/−* mice. Indeed, the defective mobi-
lization ability of epidermal HF stem cells anticipates the 
premature skin aging phenotypes of these Terc-defi  cient mice. 
Furthermore, we demonstrate that telomerase reconstitution in the 
context of very short telomeres not only corrects epidermal HF 
stem cell defects in newborn mice but is also suffi  cient to sustain 
a long-term normal organismal life span in these mice by pre-
venting organismal aging in the absence of increased cancer. It is 
important to highlight that telomerase-reconstituted mice show a 
telomere length that is indistinguishable from that of normal, 
nonreconstituted, Terc heterozygous mice, indicating that telom-
erase activity not only elongates short telomeres but is able to 
restitute a normal telomere-length homeostasis during the life 
span of these mice.
Finally, these observations support the idea that therapies 
based on telomerase activation may be effective in correcting 
the proaging effects of short telomeres in the absence of in-
creased risk of carcinogenesis. This is of particular relevance in 
the case of premature aging diseases characterized by decreased 
levels of telomerase activity and shorter telomeres, such as some 
cases of dyskeratosis congenita and aplastic anemia, which result 
in premature death associated with a defective tissue renewal 
capacity (bone marrow and skin) and increased cancer (Mason 
et al., 2005).
Figure 8.  Pronounced rescue of short telomeres in Terc-reconstituted and Terc-deﬁ  cient keratinocytes and splenocytes. (A) Telomere length histograms 
  obtained by Q-FISH on tail skin sections. The histogram shown is representative of three independent age-matched (10 mo old) pairs of Terc
+/− and telomerase-
reconstituted G3 Terc
+/−* mice (see B). Red lines facilitate visualization of short (<60 a.u.f.) and long (>600 a.u.f.) telomeres. The total number of telomere 
dots used for the quantiﬁ  cation and the percentage of short and long telomeres are indicated. Note very similar telomere length distributions in age-matched 
Terc
+/− and telomerase-reconstituted G3 Terc
+/−* mice. (B) Mean telomere length is indistinguishable between age-matched Terc
+/− and telomerase-reconstituted 
G3 Terc
+/−* mice (P = 0.98). Concomitantly, these mice show similar percentages of short telomeres (P = 0.22) and long telomeres (P = 0.70). Data are 
mean values ± SEM for three independent pairs of G3 Terc
−/− and G3 Terc
+/−* mice. (C) Telomere length histograms obtained by Q-FISH directly on 
metaphases of freshly isolated splenocytes. The histogram shown is representative of three age-matched (1–2 yr old) pairs of Terc
+/− and telomerase-
reconstituted G4 Terc
+/−* mice. In this case, arbitrary units of ﬂ  uorescence were converted into kilobases as described in Materials and methods. Red lines 
facilitate visualization of short (<10 Kb) and long (>50 Kb) telomeres. The total number of individual telomeres used for the quantiﬁ  cation and the percentage 
of short and long telomeres are indicated. Note very similar telomere length distributions in age-matched Terc
+/− and telomerase-reconstituted G4 Terc
+/−* 
mice. (D) Mean telomere length is indistinguishable between age-matched Terc
+/− and telomerase-reconstituted G4 Terc
+/−* mice (P = 0.31). Concomitantly, 
these mice show similar percentages of signal-free ends (P = 0.22), short telomeres (<10 Kb; P = 0.59), and long telomeres (>50 Kb; P = 0.75). Data are 
mean values ± SEM for three independent Terc
+/− and three independent G4 Terc
+/−* mice.JCB • VOLUME 179 • NUMBER 2 • 2007  288
Materials and methods
Generation and genotyping of mice
To generate littermate G3/G4 Terc
+/−* and G3/G4 Terc
−/− mice, G2/G3 
Terc
−/− males were crossed with Terc
+/− females (Blasco et al., 1997). 
Genotyping was performed as described in Blasco et al. (1997). Note that 
littermate G3/G4 Terc
+/−* and G3/G4 Terc
−/− mice are of an exact genetic 
background (C57BL6) as if they were derived from the same parents.
Mouse handling
Mouse colonies were generated in a pure C57BL6 background and main-
tained at the Spanish National Cancer Center under speciﬁ  c pathogen-free 
conditions in accordance with the recommendations of the Federation of 
European Laboratory Animal Science Associations.
Telomeric repeat ampliﬁ  cation protocol
Primary mouse embryonic ﬁ  broblasts (MEFs) were trypsinized and washed 
in PBS, and S-100 extracts were prepared as described in Blasco et al. 
(1997). Three protein concentrations were used for each sample (5, 2, and 
1 μg). Extension and ampliﬁ  cation reactions and electrophoresis were 
performed as described in Blasco et al. (1997). A negative control was in-
cluded by preincubating each MEF extract with RNase for 10 min at 30°C 
before the extension reaction. An internal control for PCR efﬁ  ciency was 
included (TRAPeze kit; Oncor).
Treatment regimens
To induce LRC mobilization, IFE hyperplasia, and anagen entry, tail skin 
from 71-d-old mice in the telogen (resting) phase of the hair cycle was topi-
cally treated every 48 h with TPA (20 nM in acetone) for a total of four 
doses. The control mice were treated with acetone only. 24 h after the last 
TPA treatment, mice were killed and the tail skin was analyzed. To induce 
anagen by physical stimulation, dorsal HFs in the telogen phase of the hair 
cycle were plucked from the back skin of 60-d-old G3 Terc
+/−* mice and 
the corresponding G3 Terc
−/− controls. 10 d after plucking, dorsal skins 
were harvested and prepared for histology.
Labeling of LRCs
LRCs were obtained as described in Bickenbach et al. (1986), Cotsarelis 
et al. (1990), and Braun et al. (2003), with some modiﬁ  cations. In brief, 
litters of neonatal mice were injected with 50 mg/kg of bodyweight BrdU 
(Sigma-Aldrich) diluted in PBS. Each animal received a daily injection be-
ginning at day 4 of life for a total of 5 d. After the labeling period, mice 
were allowed to grow for 60 d before the initiation of any treatment. Cells 
retaining the label at the end of the treatment were identiﬁ  ed as LRCs.
Preparation of whole mounts
Whole mounts of mouse tail epidermis were prepared as previously de-
scribed in Braun et al. (2003). In brief, after mice were killed with CO2 and 
their tails were amputated, skin was peeled from the tails and incubated in 
5 mM EDTA in PBS at 37°C for 4 h. Using forceps, intact sheets of epider-
mis were separated from the dermis and ﬁ  xed in neutral-buffered formalin 
for 2 h at room temperature. Fixed epidermal sheets were maintained in 
PBS containing 0.2% sodium azide at 4°C before labeling.
Immunoﬂ  uorescence of epidermal sheets
To detect LRCs in whole mounts of the tail skin, ﬁ  xed epidermal sheets were 
blocked and permeabilized by incubation for 30 min in a modiﬁ  ed phos-
phate buffer (Braun et al., 2003) containing 0.5% BSA and 0.5% Triton X-
100 in TBS. Subsequently, epidermal sheets were immersed for 30 min in 
2 M HCl at 37°C, incubated overnight with a mouse anti-BrdU antibody 
conjugated with ﬂ  uorescein (Roche) at 1:50 in modiﬁ  ed PB buffer, washed 
four times in PBS containing 0.2% Tween 20, and mounted in Vectashield 
(Vector Laboratories).
Confocal microscopy
A laser scanning confocal microscope (TCS-SP2-AOBS; Leica) was used to 
obtain ﬂ  uorescence images. Image stacks of 60–80 μm were obtained 
through the z dimension at steps 1.0 μm apart, using a PL APO 20×/0.70 
PH2 (Leica) as lens. Maximum intensity projections of the image stacks 
were then generated using LCS Software (Leica).
Pathology analyses
Mice were killed when they showed signs of poor health, such as reduced 
activity or weight loss, and subjected to exhaustive histopathological analysis. 
The organs we analyzed for age-related degenerative pathologies were 
the intestine (atrophy of the small and large intestine), kidney (glomerulo-
nephritis and tubular degeneration), spleen (atrophy, hemosiderosis, and 
myeloid and lymphoid hyperplasia), liver (congestion, vacuolar degeneration, 
microgranuloma, and steatosis), testis (atrophy and ectasis of seminal 
vesicles), ovary (atrophy), uterus (cystic endometrial hyperplasia), skin (benign 
hyperplasia), lung (congestion), heart (congestion and cardiomyopathy), 
and brain (calciﬁ  cation).
Histology and immunohistochemistry of skin
Tail or back skin samples were harvested from mice and ﬁ  xed overnight in 
neutral-buffered formalin at 4°C, dehydrated through graded alcohols and 
xylene, and embedded in parafﬁ  n. For determination of IFE thickness, der-
mis thickness, and HF length, dissected skin was cut parallel to the spine 
and sections were cut perpendicular to the skin surface to obtain longitudi-
nal HF sections. 5-μM sections were used for hematoxylin-eosin staining.
For immunohistochemistry, tail skin samples were sectioned at 2–3 μm 
and processed with 10 mM sodium citrate, pH 6.5, cooked under pres-
sure for 2 min. Slides were washed in water, and then in TBS Tween 20 
0.5%, blocked with peroxidase, washed with TBS Tween 20 0.5% again, 
and blocked with FBS followed by another wash. The slides were incu-
bated with the primary antibodies: rabbit monoclonal to Ki-67 antibody 
(prediluted; SP6; Master Diagnostica), rabbit polyclonal active caspase 3 
at 1:200 (R&D Systems), mouse monoclonal p63 at 1:100 (clone A48, 
Neomarker), or rabbit polyclonal K14 at 1:100 (Neomarker). Slides were 
then incubated with secondary antibodies conjugated with peroxidase 
(DakoCytomation), goat anti-rabbit (1:50) in the case of Ki-67, active 
caspase 3, K14, and mouse on mouse (Vector Laboratories) in the case of 
p63. For signal development, DAB (DakoCytomation) was used as a substrate. 
Sections were lightly counterstained with hematoxylin and analyzed by 
light microscopy.
Isolation of newborn keratinocytes
2-d-old mice were killed and soaked in betadine (5 min), in a PBS antibi-
otic solution (5 min), in 70% ethanol (5 min), and again in a PBS antibiotic 
solution (5 min). Limbs and tail were amputated and the skin was peeled 
off using forceps. Skins were then soaked in PBS (2 min), PBS antibiotic 
solution (2 min), 70% ethanol (1 min), and again in PBS antibiotic solution 
(2 min). Using forceps, each skin was ﬂ  oated on the surface of 1× trypsin 
solution (4 ml on a 60-mm cell culture plate; Sigma-Aldrich) for 16 h at 
4°C. Skins were transferred to a sterile surface. The epidermis was sepa-
rated from the dermis using forceps, minced, and stirred at 37°C for 30 min 
in serum-free Cnt-02 medium (CELLnTEC Advanced Cell Systems AG). The cell 
suspension was ﬁ  ltered through a sterile Teﬂ  on mesh (Cell Strainer 0.7 m; 
BD Biosciences) to remove corniﬁ   ed sheets. Keratinocytes were then 
collected by centrifugation (160 g) for 10 min and seeded on collagen 
I–precoated cell culture plates (BD Biosciences).
Colony-forming assay and culture conditions
1,000 mouse keratinocytes per genotype were seeded onto 10 μg/ml 
mitomycin C (2 h), treated with J2-3T3 ﬁ  broblasts (10
5 per well, 6-well dishes), 
and grown at 37°C/5% CO2 in Cnt-02 medium. After 10 d of cultivation, 
dishes were rinsed twice with PBS, ﬁ  xed in 10% formaldehyde, and then 
stained with 1% Rhodamine B to visualize colony formation. Colony size 
and number were measured using three dishes per experiment.
Telomere length analysis by Q-FISH
Freshly isolated splenocytes were obtained by squeezing the spleen through 
a cell strainer (70 μm; Nylon; BD Biosciences). Red cells were lysed by 
osmotic shock, and the splenocytes were resuspended in RPMI 1640 
containing 10% FBS and 0.55 μM β-mercaptoethanol. Concanavalin A 
(Sigma-Aldrich) was added to a concentration of 5 μg/ml and splenocytes 
were grown for 48 h. The cells were incubated with 0.1 μg/ml colcemide 
(Invitrogen) for 2 h and ﬁ  xed in methanol/acetic acid (3:1). Q-FISH was 
performed as described in Herrera et al. (1999) and Samper et al. (2000). 
To correct for lamp intensity and alignment, images from FluoroSpheres 
(ﬂ  uorescent beads; Invitrogen) were analyzed using the TFL-Telo software 
(provided by P. Lansdorp, Terry Fox Laboratory, Vancouver, Canada). Telomere 
ﬂ   uorescence values were extrapolated from the telomere ﬂ  uorescence  of 
lymphoma cell lines LY-R (R cells) and LY-S (S cells) with known telomere 
lengths of 80 and 10 kb, respectively.  There was a linear correlation (r
2 = 
0.999) between the ﬂ  uorescence intensity of the R and S telomeres. We re-
corded the images using a camera (CCK; COHU) on a ﬂ  uorescence micro-
scope (DMRb; Leica). A mercury vapor lamp (CS 100 W-2; Philips) was used 
as a source. We captured the images using the Q-FISH software (Leica) in 
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We used the TFL-Telo software (Zijlmans et al., 1997) to quantify the 
ﬂ  uorescence intensity of telomeres from at least 10 metaphases for each 
data point.
Exponentially growing primary keratinocytes were ﬁ  xed in methanol/
acetic acid, and Q-FISH of interphase nucleus was performed. For Q- FISH 
in tail skin, parafﬁ  n-embedded tail sections were deparafﬁ  nated. Both ke-
ratinocytes and deparafﬁ   nated sections of tail skin were hybridized 
with a PNA-telomeric probe and telomere ﬂ  uorescence was determined 
as described in Gonzalez-Suarez et al. (2000) and Muñoz et al. (2005). 
More than 60 nuclei from each mouse and condition were captured at 100 
magniﬁ  cation using a microscope (CTR MIC; Leica) and a camera (High 
Performance CCD; COHU). Telomere ﬂ  uorescence was integrated using 
spot IOD analysis in the TFL-TELO program (Zijlmans et al., 1997).
Cytogenetic analysis using telomere Q-FISH on metaphases
Metaphases from keratinocytes of the indicated genotypes were obtained 
by adding 1 μg/ml colcemide (Invitrogen) to primary keratinocytes during 
5 h and then ﬁ  xing in methanol/acetic acid (3:1). Q-FISH was performed 
as described in Herrera et al. (1999) and Samper et al. (2000). For analy-
sis of chro  mosomal aberrations, 50 metaphases per genotype were ana-
lyzed by superimposing the telomere image on the DAPI image using the 
TFL-telo software.
Statistical analysis
Unless otherwise indicated, data are given as mean values ± SEM of 
n and have been analyzed for statistically signiﬁ  cant differences using 
t test.
Online supplemental material
Fig. S1 shows rescue of HF stem cell mobilization defects in late generation 
telomerase-reconstituted G4 Terc
+/−* mice. Fig. S2 shows similar prolifera-
tion rates in G3 Terc
−/− and G3 Terc
+/−* tail skin. Fig. S3 shows no detectable 
apoptosis in the skin of G3 Terc
+/−* mice and G3 Terc
−/− siblings. Fig. S4 
shows no differences in p63 expression between Terc
−/− and G3 Terc
+/−* 
tail skin. Fig. S5 shows no differences in keratin 14 expression between 
Terc
−/− and G3 Terc
+/−* tail skin. Online supplemental material is available 
at http://www.jcb.org/cgi/content/full/jcb.200704141/DC1.
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